Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Real-time motion analysis reveals cell directionality as an indicator of breast cancer progression.

Weiger MC, Vedham V, Stuelten CH, Shou K, Herrera M, Sato M, Losert W, Parent CA.

PLoS One. 2013;8(3):e58859. doi: 10.1371/journal.pone.0058859. Epub 2013 Mar 19.

2.

LPA, HGF, and EGF utilize distinct combinations of signaling pathways to promote migration and invasion of MDA-MB-231 breast carcinoma cells.

Harrison SM, Knifley T, Chen M, O'Connor KL.

BMC Cancer. 2013 Oct 27;13:501. doi: 10.1186/1471-2407-13-501.

3.

LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.

Komachi M, Tomura H, Malchinkhuu E, Tobo M, Mogi C, Yamada T, Kimura T, Kuwabara A, Ohta H, Im DS, Kurose H, Takeyoshi I, Sato K, Okajima F.

Carcinogenesis. 2009 Mar;30(3):457-65. doi: 10.1093/carcin/bgp011. Epub 2009 Jan 7.

4.

β-Arrestin2 regulates lysophosphatidic acid-induced human breast tumor cell migration and invasion via Rap1 and IQGAP1.

Alemayehu M, Dragan M, Pape C, Siddiqui I, Sacks DB, Di Guglielmo GM, Babwah AV, Bhattacharya M.

PLoS One. 2013;8(2):e56174. doi: 10.1371/journal.pone.0056174. Epub 2013 Feb 6.

5.

Characterization of spontaneous and TGF-β-induced cell motility of primary human normal and neoplastic mammary cells in vitro using novel real-time technology.

Mandel K, Seidl D, Rades D, Lehnert H, Gieseler F, Hass R, Ungefroren H.

PLoS One. 2013;8(2):e56591. doi: 10.1371/journal.pone.0056591. Epub 2013 Feb 14. Erratum in: PLoS One. 2013;8(4). doi:10.1371/annotation/e799099f-9509-4769-b761-853fccec4541.

6.

Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms.

Boucharaba A, Guillet B, Menaa F, Hneino M, van Wijnen AJ, Clézardin P, Peyruchaud O.

Oncol Res. 2009;18(4):173-84. Erratum in: Oncol Res. 2009;18(7):357. Philippe, Clézardin [corrected to Clézardin, Philippe]; Oliver, Peyruchaud [corrected to Peyruchaud, Oliver].

PMID:
20112503
7.

A novel circular invasion assay mimics in vivo invasive behavior of cancer cell lines and distinguishes single-cell motility in vitro.

Kam Y, Guess C, Estrada L, Weidow B, Quaranta V.

BMC Cancer. 2008 Jul 14;8:198. doi: 10.1186/1471-2407-8-198.

8.

Epidermal growth factor stimulation can substitute for c-Src overexpression in promoting breast carcinoma invasion.

Lotz M, Wang HH, Cance W, Matthews J, Pories S.

J Surg Res. 2003 Feb;109(2):123-9.

PMID:
12643853
10.

Lysophosphatidic acid induces MDA-MB-231 breast cancer cells migration through activation of PI3K/PAK1/ERK signaling.

Du J, Sun C, Hu Z, Yang Y, Zhu Y, Zheng D, Gu L, Lu X.

PLoS One. 2010 Dec 30;5(12):e15940. doi: 10.1371/journal.pone.0015940.

11.

MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer.

Guo QJ, Mills JN, Bandurraga SG, Nogueira LM, Mason NJ, Camp ER, Larue AC, Turner DP, Findlay VJ.

Breast Cancer Res. 2013;15(4):R70.

12.

PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population.

Yoon CH, Kim MJ, Lee H, Kim RK, Lim EJ, Yoo KC, Lee GH, Cui YH, Oh YS, Gye MC, Lee YY, Park IC, An S, Hwang SG, Park MJ, Suh Y, Lee SJ.

J Biol Chem. 2012 Jun 1;287(23):19516-27. doi: 10.1074/jbc.M111.337428. Epub 2012 Apr 16.

13.

Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice.

Li H, Wang D, Zhang H, Kirmani K, Zhao Z, Steinmetz R, Xu Y.

Mol Cancer Ther. 2009 Jun;8(6):1692-701. doi: 10.1158/1535-7163.MCT-08-1106. Epub 2009 Jun 9.

14.

Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.

Wendt MK, Smith JA, Schiemann WP.

Oncogene. 2010 Dec 9;29(49):6485-98. doi: 10.1038/onc.2010.377. Epub 2010 Aug 30.

16.

Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells.

Baugher PJ, Krishnamoorthy L, Price JE, Dharmawardhane SF.

Breast Cancer Res. 2005;7(6):R965-74. Epub 2005 Sep 30.

17.

MUC1 drives c-Met-dependent migration and scattering.

Horm TM, Bitler BG, Broka DM, Louderbough JM, Schroeder JA.

Mol Cancer Res. 2012 Dec;10(12):1544-54. doi: 10.1158/1541-7786.MCR-12-0296. Epub 2012 Nov 27.

18.

E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells.

van Horssen R, Hollestelle A, Rens JA, Eggermont AM, Schutte M, Ten Hagen TL.

Breast Cancer Res Treat. 2012 Nov;136(2):365-77. doi: 10.1007/s10549-012-2261-8. Epub 2012 Sep 29.

PMID:
23053649
19.

Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis.

Chen H, Wu X, Pan ZK, Huang S.

Cancer Res. 2010 Dec 1;70(23):9979-90. doi: 10.1158/0008-5472.CAN-10-2394. Epub 2010 Nov 30.

20.

Enhancement of the migration of metastatic human breast cancer cells by phosphatidic acid.

Sliva D, Mason R, Xiao H, English D.

Biochem Biophys Res Commun. 2000 Feb 16;268(2):471-9.

PMID:
10679229
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk